TheraDoc, Version 5.4.6
This Health IT Module is compliant with the ONC Certification Criteria for Health IT and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.
- Developer name: Premier Healthcare Solutions, Inc
- Date certified: February 14, 2025
- Product name and version: TheraDoc, version 5.4.6
- ONC-ACB Certification ID: 15.99.04.3033.TH03.05.20.0.250214
- CHPL Product ID: 15.99.04.3033.TH03.05.20.0.250214
- Certification criteria: 170.315(d)(1); 170.315(d)(2); 170.315(d)(3); 170.315(d)(7); 170.315(d)(12); 170.315(d)(13); 170.315(f)(5); 170.315(f)(6); 170.315(g)(4); 170.315(g)(5)
- CQMs: None
Additional software relied upon to demonstrate its compliance with certification criteria: None
| Costs of TheraDoc Certified Health IT | ||
|---|---|---|
| Capability | Description of Capability | Costs or Fees |
| Transmission to public health agencies – electronic case reporting 170.315(f)(5) |
This capability supports the creation and electronic transmission of case reports that comply with eCR version standards as supported by the eCR Now Fast Health Interoperability Resources (FHIR) application. |
Additional fees are required for the implementation of TheraDoc Electronic Case Reporting (eCR). These include a mix of recurring annual feature/functionality costs, training and support costs, and one-time costs associated with data acquisition to meet the reporting requirements. There may be additional fees to receive, evaluate, and report additional data components as federal eCR reporting requirements change over time. No additional software requirements, contracts, or third-party engagements are needed to use TheraDoc eCR functionality. |
| Transmission to public health agencies – antimicrobial use and resistance reporting 170.315(f)(6) |
This capability supports the creation and electronic reporting of the following reports to the National Healthcare Safety Network (NHSN):
|
Additional costs may be required to implement TheraDoc Antimicrobial Use and Resistance (AUR) Reporting functionality, depending on the current scope of contracted solutions. The costs are specifically tied to implementation fees for data-enabled functionality. There may be additional fees for compliance purposes as additional regulations are released in the future. No additional software requirements, contracts, or third-party engagements are needed to use TheraDoc AUR functionality. |
Standards Version Advancement Process (SVAP) Notice
Under the SVAP, the Office of the National Coordinator (ONC) for Health IT allows vendors to voluntarily update certified health IT products to use more advanced versions of standards than are adopted in ONC Certification Criteria for Health IT. For its certified NHSN AUR Antimicrobial Use and Resistance (AUR) functionality, TheraDoc remains compliant with the CDA versions supported by NHSN in conjunction with the following SVAP-approved standards:
| CDA | SVAP-Approved Standard |
| Antimicrobial Use and Resistance (AUR) Antimicrobial Resistance Option (ARO) Report (Numerator) | HL7® CDA® R2 Implementation Guide: Healthcare Associated Infection (HAI) Reports, Release 3 – US Realm, December 2020 |
| Antimicrobial Resistance Option (ARO) Summary Report (Denominator) | HL7® CDA® R2 Implementation Guide: Healthcare Associated Infection (HAI) Reports, Release 3 – US Realm, December 2020 |
| Antimicrobial Use (AUP) Summary Report (Numerator and Denominator) | Health Level 7 (HL7®) Implementation Guide for CDA® Release 2 – Level 3: Healthcare Associated Infection (HAI) Reports, Release 1, U.S. Realm, August 2013 |
Because the AUR CDA versions supported in TheraDoc align with year-specific NHSN reporting requirements, the CDA version updates will not affect real-world interoperability for AUR reporting.